Opko Current Deferred Revenue from 2010 to 2026
| OPK Stock | USD 1.21 0.04 3.20% |
Current Deferred Revenue | First Reported 2001-03-31 | Previous Quarter 3.8 M | Current Value 5.8 M | Quarterly Volatility 29.9 M |
Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 118.5 M, Interest Expense of 57.3 M or Total Revenue of 435.2 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.0011 or PTB Ratio of 0.82. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
Opko | Current Deferred Revenue | Build AI portfolio with Opko Stock |
Historical Current Deferred Revenue data for Opko Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Opko Health represents a compelling investment opportunity.
Latest Opko Health's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Opko Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Opko Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Opko Health's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Opko Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 29,562,345 | |
| Geometric Mean | 11,624,968 | |
| Coefficient Of Variation | 86.31 | |
| Mean Deviation | 21,679,946 | |
| Median | 28,190,565 | |
| Standard Deviation | 25,516,371 | |
| Sample Variance | 651.1T | |
| Range | 73.4M | |
| R-Value | 0.31 | |
| Mean Square Error | 628.9T | |
| R-Squared | 0.09 | |
| Significance | 0.23 | |
| Slope | 1,553,438 | |
| Total Sum of Squares | 10417.4T |
Opko Current Deferred Revenue History
About Opko Health Financial Statements
Opko Health investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 43.4 M | 28.2 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Opko Health Correlation against competitors. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.13) | Earnings Share (0.24) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.